The hard part of animal-free safety assessment is a unit conversion. A cell assay reports a concentration in a well; an authority needs a dose a person could plausibly receive. That translation is toxicokinetics, one of ASPA's three pillars alongside hazard and exposure [6]. Fraunhofer ITEM's contribution sits on that pillar: physiologically based kinetic models that represent the human body in equations, combining anatomical and physiological data with substance-specific parameters to calculate absorption, distribution, metabolism and excretion [10]. Sylvia Escher, the Fraunhofer ITEM scientist quoted in the account, describes the purpose without ornament: converting doses measured in the Petri dish into realistic doses in the human body [13].
Inhalation is where that conversion has been thinnest. Existing kinetic models for inhaled substances were built either for gases and vapours or for airborne particles, and represented the regions of the lung only in simplified form [12]. The Fraunhofer model is aimed at inhalable substances including both gases and aerosols made of liquid droplets or solid particles [11], and the same group can determine the relevant absorption, metabolism and excretion parameters experimentally for airborne exposure [14].
Then there is the paperwork, which is probably what will govern how fast anyone can use this. ASPA demands a precise justification for each interim decision, which in turn forces a stated uncertainty at each step [8]. At roughly 55 assessment elements [7], one pass over a single substance yields at least 55 documented judgement calls [17]. That is the arithmetic behind ASPA-assist, the software that steps users through the modules and standardises the report [9]; the tooling exists because the burden is real.
The thing this doesn't tell you is how well any of it performs. There is no concordance figure against animal-study outcomes, no count of substances carried through the full workflow, no time or cost per assessment, and no acceptance decision by any regulator [18]. It is also an institutional account of a workflow from one of the institutes that built it, quoting its own scientist [19]. Neither of those is disqualifying; both set the discount rate.
My read is that the change here is procedural rather than evidential. A fixed module structure with standardised reporting is something a chemical safety team can test this quarter, by pushing an existing dossier through it and marking every step where the justification will not hold. That is more useful for planning than the Commission roadmap it implements [2], because a roadmap cannot fail an audit and a 55-module decision trail can.
